KR950702118A - 17-Alkylketone steroids useful as 5-α-reductase inhibitors - Google Patents

17-Alkylketone steroids useful as 5-α-reductase inhibitors

Info

Publication number
KR950702118A
KR950702118A KR1019940704802A KR19940704802A KR950702118A KR 950702118 A KR950702118 A KR 950702118A KR 1019940704802 A KR1019940704802 A KR 1019940704802A KR 19940704802 A KR19940704802 A KR 19940704802A KR 950702118 A KR950702118 A KR 950702118A
Authority
KR
South Korea
Prior art keywords
alkylketone
reductase inhibitors
steroids useful
steroids
useful
Prior art date
Application number
KR1019940704802A
Other languages
Korean (ko)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950702118A publication Critical patent/KR950702118A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
KR1019940704802A 1992-06-30 1994-12-29 17-Alkylketone steroids useful as 5-α-reductase inhibitors KR950702118A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929213835A GB9213835D0 (en) 1992-06-30 1992-06-30 Compounds
PCT/US1993/006238 WO1994000125A1 (en) 1992-06-30 1993-06-30 17-ALKYLKETONE STEROIDS USEFUL AS 5-α-REDUCTASE INHIBITORS

Publications (1)

Publication Number Publication Date
KR950702118A true KR950702118A (en) 1995-06-19

Family

ID=10717920

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940704802A KR950702118A (en) 1992-06-30 1994-12-29 17-Alkylketone steroids useful as 5-α-reductase inhibitors

Country Status (23)

Country Link
EP (1) EP0651643A4 (en)
JP (1) JPH08500821A (en)
KR (1) KR950702118A (en)
CN (1) CN1095382A (en)
AP (1) AP412A (en)
AU (1) AU4545993A (en)
BG (1) BG99313A (en)
BR (1) BR9306748A (en)
CA (1) CA2138956A1 (en)
CZ (1) CZ334694A3 (en)
FI (1) FI946189A0 (en)
GB (1) GB9213835D0 (en)
HU (1) HUT69409A (en)
IL (1) IL106158A0 (en)
MA (1) MA22927A1 (en)
MX (1) MX9303970A (en)
NO (1) NO945074L (en)
OA (1) OA10122A (en)
RU (1) RU94046378A (en)
SI (1) SI9300350A (en)
SK (1) SK159994A3 (en)
WO (1) WO1994000125A1 (en)
ZA (1) ZA934645B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925774A (en) * 1991-01-07 1999-07-20 Pherin Corporation Estrenes for inducing hypothalamic effects
WO1993023050A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. NEW DELTA-17 AND DELTA-20 OLEFINIC AND SATURATED 17β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic
JP2015129095A (en) 2013-12-19 2015-07-16 ロレアル composition
US20210139530A1 (en) * 2018-02-11 2021-05-13 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Steroid derivative regulators, method for preparing the same, and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954446A (en) * 1988-05-25 1990-09-04 Smithkline Beecham Corporation Aromatic steroid 5-α-reductase inhibitors

Also Published As

Publication number Publication date
IL106158A0 (en) 1993-10-20
AP412A (en) 1995-09-29
CZ334694A3 (en) 1995-10-18
NO945074D0 (en) 1994-12-29
SI9300350A (en) 1993-12-31
CN1095382A (en) 1994-11-23
BR9306748A (en) 1998-12-08
OA10122A (en) 1996-12-18
HUT69409A (en) 1995-09-28
AP9300542A0 (en) 1993-07-31
RU94046378A (en) 1996-10-10
FI946189A (en) 1994-12-30
FI946189A0 (en) 1994-12-30
EP0651643A1 (en) 1995-05-10
AU4545993A (en) 1994-01-24
GB9213835D0 (en) 1992-08-12
WO1994000125A1 (en) 1994-01-06
CA2138956A1 (en) 1994-01-06
BG99313A (en) 1995-09-29
NO945074L (en) 1995-02-16
MX9303970A (en) 1994-04-29
EP0651643A4 (en) 1995-10-04
JPH08500821A (en) 1996-01-30
MA22927A1 (en) 1994-04-01
SK159994A3 (en) 1996-01-10
ZA934645B (en) 1994-01-25

Similar Documents

Publication Publication Date Title
CY2004002I2 (en) ANDROSTENONE DERIVATIVE
DE69327741D1 (en) Photopolymerizable composition
FI934735A (en) Form Panel
NO931117D0 (en) STEROID DERIVATIVES
DE59306558D1 (en) Analyzer
DE69320397D1 (en) Photopolymerizable composition
FI931121A (en) BOCKNINGSPRESS FOR FRAMSTAELLNING AV BOEJDA GLASRUTOR
DE69526475T2 (en) 5-alpha-reductase inhibitors
FI946106A (en) Steroidal glycosides
KR950702118A (en) 17-Alkylketone steroids useful as 5-α-reductase inhibitors
DE69333328D1 (en) Photopolymerizable compositions
FI946081A (en) Steroidal beta-O-cellobioside hepta-alkanoate method
DE59410459D1 (en) p-dinitrosobenzene
FI931411A (en) TESTING DEVICES FOR BROMSSYSTEM
DK0599461T3 (en) Healable compositions
FI931943A (en) FRAMEWORK FOR FRAMSTAELLNING AV EN SILVERNITRATLOESNING
NO933444L (en) Line Events
FI930710A0 (en) ANORDINATION FOR OEVERVAKNING AV VAETSKENIVAO
KR930023719U (en) Carrying for CAISSON
KR930023640U (en) Full chiller
FI934756A0 (en) ANORDINATION FOR AVLAEGSNANDE AV UTSTANSADE DELAR
SE9300030D0 (en) NOVEL COLON- OR ILEUM-SPECIFIC STEROID DERIVATIVES
BR9202975A (en) PSEUDO JOLA LUMINOSA
FI932629A0 (en) remover
NO950391D0 (en) Compositions

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid